Skip to main content
. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691

Figure A.4.

Figure A.4

(A) NADH ubiquinone oxidoreductase, illustrating molecular mode of action and binding site of Rotenone (and Rotenone‐like compounds) IMS: inter‐membrane space (based on Lummen, 1998). (B) Dose‐dependent relative affinities of rotenone to the inhibitory site of CI (for more details, see Grivennikova et al., 1997. Reprinted from Grivennikova et al., 1997, Fig. 1, copyright (1997) with permission from Elsevier)